Templin K, Shively M, Riley J
MICU/CCU, Dept of Veterans Affairs Medical Center, San Diego, CA 92161.
Am J Crit Care. 1993 Jan;2(1):88-95.
To determine the accuracy of activated partial thromboplastin time and prothrombin time studies when samples are drawn through heparinized arterial lines.
A total sample of 90 grouped blood samples (from 30 subjects) was used. Patients were all male, with a mean age of 65 and were studied within 24 hours of percutaneous transluminal coronary angioplasty. Each patient had three venous control and arterial line sample sets (a total of 90 blood samples) drawn when routinely ordered for monitoring therapy. For the arterial line sample, a discard volume of the deadspace, deadspace + 2 mL, or deadspace + 4 mL was randomly assigned for each sample. The venous control volumes were the same for all three sample sets.
A 2 x 3 repeated measures analysis of variance was used to analyze the results. The independent variables were the source of the sample (venous vs arterial) and the discard volume of arterial blood (deadspace, deadspace + 2 mL, deadspace + 4 mL). The dependent variables were the activated partial thromboplastin time and prothrombin time values. Mean arterial activated partial thromboplastin time values were significantly higher than the corresponding venous values. Mean activated partial thromboplastin time values were not significantly different among the discard volumes of blood drawn. However, there was a significant source by volume interaction. Tukey post-hoc comparisons of venous-arterial activated partial thromboplastin time differences among the three volumes showed significant differences between deadspace volume and deadspace + 2 mL, and deadspace volume and deadspace + 4 mL. There was no significant difference between deadspace + 2 mL and deadspace + 4 mL volumes.
Results indicated that the minimal amount of discard volume for accurate activated partial thromboplastin time values in this population of percutaneous transluminal coronary angioplasty patients was the catheter deadspace volume plus 2 mL (total 3.6 mL).
确定通过肝素化动脉导管采集样本时活化部分凝血活酶时间和凝血酶原时间检测的准确性。
使用了总共90份分组血样(来自30名受试者)。患者均为男性,平均年龄65岁,在经皮腔内冠状动脉成形术24小时内进行研究。每位患者在按常规医嘱进行治疗监测时采集三组静脉对照样本和动脉导管样本(共90份血样)。对于动脉导管样本,每个样本随机分配死腔、死腔 + 2 mL或死腔 + 4 mL的弃血体积。三组样本的静脉对照体积相同。
采用2×3重复测量方差分析来分析结果。自变量为样本来源(静脉血与动脉血)和动脉血弃血体积(死腔、死腔 + 2 mL、死腔 + 4 mL)。因变量为活化部分凝血活酶时间和凝血酶原时间值。动脉血活化部分凝血活酶时间的平均值显著高于相应的静脉血值。不同弃血体积的活化部分凝血活酶时间平均值无显著差异。然而,存在显著的来源与体积交互作用。对三组体积下静脉 - 动脉活化部分凝血活酶时间差异进行Tukey事后比较,结果显示死腔体积与死腔 + 2 mL之间以及死腔体积与死腔 + 4 mL之间存在显著差异。死腔 + 2 mL与死腔 + 4 mL体积之间无显著差异。
结果表明,在这群经皮腔内冠状动脉成形术患者中,为获得准确的活化部分凝血活酶时间值所需的最小弃血体积是导管死腔体积加2 mL(总计3.6 mL)。